Secondary prevention of fragility fractures: where do we stand during the COVID-19 pandemic?

J Endocrinol Invest. 2021 Nov;44(11):2521-2524. doi: 10.1007/s40618-021-01552-1. Epub 2021 Apr 17.
No abstract available

Keywords: Bone fragility; COVID-19; Fractures risk; Fragility fractures; Osteoporosis.

Publication types

  • Letter

MeSH terms

  • Aged
  • Bone Density Conservation Agents / therapeutic use
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Female
  • Health Services Needs and Demand
  • Humans
  • Male
  • Osteoporosis* / complications
  • Osteoporosis* / prevention & control
  • Osteoporotic Fractures* / mortality
  • Osteoporotic Fractures* / prevention & control
  • Osteoporotic Fractures* / psychology
  • Preventive Health Services / standards*
  • Quality of Life*
  • Risk Adjustment* / methods
  • Risk Adjustment* / standards
  • Risk Factors
  • SARS-CoV-2
  • Secondary Prevention / methods

Substances

  • Bone Density Conservation Agents